SEO URLwww.firestrike.ai/deals/revolution-medicines-abbvie-acquisition-2026
acquisitionAnnounced · Jan 7, 2026BiotechSource · Community DiscussionsArticle · Expectations
AbbVie acquires Revolution Medicines
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
—
Target
Revolution Medicines
NASDAQ: RVMD · Redwood City, California
Acquirer
AbbVie
Full Acquisition
Status
Pending
AbbVie agreed to acquire Revolution Medicines. Reported deal value: Undisclosed. Status: Pending. Sector: Biotech. Target headquarters context: Redwood City, California, United States.
This page summarizes publicly available information about the transaction as of 2026-01-07. Figures and status may change as filings and press coverage update.
AbbVie is currently in advanced negotiations to acquire Revolution Medicines , a biotech company specializing in cancer drugs
Deal timeline
Announced
Jan 7, 2026 · el-balad.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotech. Figures and status may change as sources update.
Sources: el-balad.com · Primary article · FireStrike proprietary index